4,5,6,7-tetrabromo-2-azabenzimidazole and 4,5,6,7-tetrabromobenzimidazole
4,5,6,7-tetrabromo-2-azabenzimidazole has been researched along with 4,5,6,7-tetrabromobenzimidazole in 11 studies
Research
Studies (11)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (45.45) | 29.6817 |
2010's | 6 (54.55) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Andrzejewska, M; Bain, J; Cesaro, L; Elliott, M; Kazimierczuk, Z; Meggio, F; Pagano, MA; Pinna, LA; Ruzzene, M; Sarno, S | 1 |
Bretner, M; Kopańska, K; Krzywińska, E; Muszyńska, G; Najda-Bernatowicz, A; Orzeszko, A; Łebska, M | 1 |
Leung, KK; Shilton, BH | 1 |
Bretner, M; Chojnacki, K; Skierka, K; Wielechowska, M; Wińska, P | 1 |
Jarhad, DB; Jeong, LS; Kim, HR; Mashelkar, KK; Noh, M | 1 |
Chen, T; Chen, Y; Feng, F; Guo, Q; Lin, H; Liu, W; Liu, Z; Qiao, Y; Qu, W; Sun, H; Yang, H | 1 |
Bretner, M; Shugar, D; Szyszka, R; Zastapiło, K; Zień, P | 1 |
Abramczyk, O; Bretner, M; Domańska, K; Szyszka, R; Zień, P | 1 |
Bretner, M; Duncan, JS; Litchfield, DW; Shugar, D; Skierski, J; Zien, P | 1 |
Bilińska-Chomik, A; Bretner, M; Kuś, A; Makowska, M; Wińska, P; Łukowska-Chojnacka, E | 1 |
Bretner, M; Maj, P; Makowska, M; Poznański, J; Shugar, D; Wielechowska, M; Winiewska, M | 1 |
Reviews
3 review(s) available for 4,5,6,7-tetrabromo-2-azabenzimidazole and 4,5,6,7-tetrabromobenzimidazole
Article | Year |
---|---|
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics.
Topics: Animals; Biological Products; Disease; Dyrk Kinases; Enzyme Activation; Humans; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases | 2018 |
Small molecule modulators targeting protein kinase CK1 and CK2.
Topics: Animals; Casein Kinase I; Casein Kinase II; Drug Discovery; Humans; Molecular Docking Simulation; Protein Kinase Inhibitors; Small Molecule Libraries | 2019 |
Tetrabromobenzotriazole (TBBt) and tetrabromobenzimidazole (TBBz) as selective inhibitors of protein kinase CK2: evaluation of their effects on cells and different molecular forms of human CK2.
Topics: Apoptosis; Benzimidazoles; Casein Kinase II; Cell Membrane Permeability; Cell Proliferation; Evaluation Studies as Topic; HeLa Cells; Humans; Protein Isoforms; Triazoles | 2005 |
Other Studies
8 other study(ies) available for 4,5,6,7-tetrabromo-2-azabenzimidazole and 4,5,6,7-tetrabromobenzimidazole
Article | Year |
---|---|
Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole.
Topics: Animals; Apoptosis; Benzimidazoles; Casein Kinase II; Catalytic Domain; Humans; Jurkat Cells; Kinetics; Models, Molecular; Molecular Structure; Mutation; Phosphorylation; Rats; Structure-Activity Relationship | 2004 |
Synthesis of new analogs of benzotriazole, benzimidazole and phthalimide--potential inhibitors of human protein kinase CK2.
Topics: Benzimidazoles; Casein Kinase II; Humans; Phthalimides; Protein Kinase Inhibitors; Structure-Activity Relationship; Triazoles | 2009 |
Quinone reductase 2 is an adventitious target of protein kinase CK2 inhibitors TBBz (TBI) and DMAT.
Topics: Benzimidazoles; Casein Kinase II; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Delivery Systems; Humans; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Secondary; Protein Structure, Tertiary; Quinone Reductases | 2015 |
Synthesis, in vitro antiproliferative activity and kinase profile of new benzimidazole and benzotriazole derivatives.
Topics: Antineoplastic Agents; Benzimidazoles; Casein Kinase II; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Humans; Molecular Structure; Protein Kinase Inhibitors; Structure-Activity Relationship; Triazoles | 2017 |
Selectivity of 4,5,6,7-tetrabromobenzimidazole as an ATP-competitive potent inhibitor of protein kinase CK2 from various sources.
Topics: Adenosine Triphosphate; Animals; Benzimidazoles; Binding, Competitive; Candida tropicalis; Casein Kinase II; Enzyme Inhibitors; In Vitro Techniques; Kinetics; Liver; Neurospora crassa; Protein Serine-Threonine Kinases; Rats; Saccharomyces cerevisiae; Triazoles | 2003 |
TBBz but not TBBt discriminates between two molecular forms of CK2 in vivo and its implications.
Topics: Benzimidazoles; Binding, Competitive; Casein Kinase II; Cell Division; Dose-Response Relationship, Drug; Enzyme Activation; Protein Biosynthesis; Protein Serine-Threonine Kinases; Protozoan Proteins; Ribosomal Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Triazoles | 2003 |
Design and synthesis of CK2 inhibitors.
Topics: Benzimidazoles; Casein Kinase II; Drug Design; Humans; Inhibitory Concentration 50; Protein Kinase Inhibitors; Triazoles | 2011 |
Thermodynamic parameters for binding of some halogenated inhibitors of human protein kinase CK2.
Topics: Benzimidazoles; Binding Sites; Calorimetry; Calorimetry, Differential Scanning; Casein Kinase II; Drug Design; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Ligands; Methylation; Microscopy, Fluorescence; Protein Binding; Static Electricity; Temperature; Thermodynamics; Triazoles | 2015 |